PHCY 6185 - T Woods Fall 10


Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: m Pharm Assoc. 2004;44:467-471. Arch Intern Med. 1998;158:1641-7. Anticoagulation Anticoagulation • Limitations – Retrospective review, no control group – 6 months – Patients were not excluded if their therapy was dc’d for a procedure • Conclusions – Community pharmacists effectively manage anticoag therapy, results of this clinic are similar to those of clinics managed by pharmacists in other settings J Am Pharm Assoc. 2004;44:467-471 . MISSION MISSION To provide continuity of care for patients by optimizing drug therapy outcomes through collaboration with other health care providers while advancing the profession of pharmacy. Pharmacist­Driven Clinical Services Pharmacist­Driven Clinical Services • Patient Benefits – – – – – – – Decrease morbidity and mortality Reduce health care costs Continuity of Care Reduce long visits for chronic­care Allows more time for acute­care Reduce cost of care Improves patient care • Physician Benefits Pharmacist­Driven Clinical Services Pharmacist­Driven Clinical Services • Pharmacist Benefits – – – Evolution of pharmacy Ability to provide continuity of care Patie...
View Full Document

  • Fall '08
  • Vandel
  • drug therapy, medication therapy management, Pharmaceutical Care, Therapy Management Medication Therapy Management

{[ snackBarMessage ]}

Ask a homework question - tutors are online